Is celiac disease having a significant impact on your daily life? You may be eligible for a clinical study. The ASPIRION study is a phase 2 study looking into a new, investigational study drug (amlitelimab) for patients with celiac disease.
Continue ReadingNew Phase 2 Clinical Trial: TEV-CeD2 Study
Continue ReadingThe ILLUMINATE-101 Study is a phase 2 clinical research study evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.
Continue ReadingMany conventional brands actually have a hidden source of gluten in the ingredients list!
Continue ReadingWhat if there was a way to help your immune system become more tolerant of gluten? That’s the potential of VTP-1000, an investigational immunotherapy being studied in the AVALON celiac disease clinical trial.
Continue ReadingThe Celiac Disease Foundation is committed to accelerating research aimed at finding potential treatments and cures for celiac disease beyond the gluten-free diet. In order to do this, we need…
Continue ReadingA new international study published in the journal Gastroenterology sheds light on the extensive economic burden of celiac disease. In addition to the cost of gluten-free foods, the authors address…
Continue ReadingNewly released data from Chugai Pharmaceuticals shows their drug candidate DONQ52 potently blocks gluten-specific t-cells and is ready for continued development. So, what does this mean for the celiac disease community?
Continue ReadingThe Celiac Disease Foundation on May 22 awarded its first Celiac Disease Policy Leadership Award to U.S. Representative Betty McCollum (MN-04) for her distinguished service and advocacy on behalf of the celiac disease patient community. Among other initiatives, she established the bipartisan Congressional Celiac Disease Caucus, which has significantly increased federal recognition of celiac disease.
Continue ReadingOn May 20 the Disease Foundation hosted its third annual award reception at Digestive Disease Week in Washington, D.C. From prestigious global research prizes to inaugural student and policy leadership awards, the event spotlighted the extraordinary contributions of individuals dedicated to improving the lives of those affected by celiac disease.
Continue ReadingDear Celiac Disease Foundation Community, For more than three decades, the Celiac Disease Foundation has been dedicated to improving the lives of those affected by celiac disease through research, advocacy, and education. What began as a grassroots effort has grown into a global organization, leading the charge in accelerating diagnosis,...